Maternal Serum Vascular Endothelial Growth Factor in Patients with Preeclampsia | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 14, Volume 69, Issue 1, October 2017, Page 1634-1640 PDF (471.99 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.12816/0040112 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Mohammed Salah El-Sokkary; Tamer Ahmed El-Refaie; Noha Bassiouny Hassan Mostafa; Mona Mohamed Soliman Elaassar | ||||
| Obstetrics and Gynecology Department, Faculty of Medicine, Ain Shams University | ||||
| Abstract | ||||
| Background: Vascular endothelial growth factor and placental growth factor levels were significantly lower in patients of sever or early onset (34 weeks or less gestational age at onset of PET) pre-eclampsia than in controls. Aim of the Work: Will there be a rise in serum vascular endothelial growth factor in pregnant women suffering from preeclampsia than in normotensive pregnant women. Patients and Methods: 150 pregnant women from 28 weeks of gestation till term will be enrolled into this comparative clinical trial at the time of their antenatal visit to the outpatient department of obstetrics and gynecology Ain Shams University maternal hospital. Results: We recruited 150 pregnant women after 28 weeks of gestation and they were classified into 3 groups: Group1:50 pregnant women with mild preeclampsia from 28 weeks of gestation till term, Group2: 50 pregnant women with severe preeclampsia from 28 weeks of gestation till term and Group 3: 50 normal pregnant women serving as controls. Conclusion: We conclude that serum VEGF level measured after 28 weeks of gestation can be used as a predictor for preeclampsia and its degrees (mild and severe) with high sensitivity and specificity. | ||||
| Keywords | ||||
| Nulliparous; Gastroesophageal; Hypochondrium; Cerebrovascular | ||||
|
Statistics Article View: 83 PDF Download: 218 |
||||
